Welcome to our dedicated page for Lifeway Foods SEC filings (Ticker: LWAY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Lifeway Foods's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Lifeway Foods's regulatory disclosures and financial reporting.
Form 144 Notice of Proposed Sale filed by Lifeway Foods director Jason Scher, indicating intent to sell 16,366 shares of common stock with an aggregate market value of $396,734.75 through Morgan Stanley Smith Barney on NASDAQ.
The securities to be sold were acquired through multiple private transactions as compensation between 2021-2023:
- 3,802 shares each on 07/15/2021, 07/15/2022, and 07/15/2023
- 2,221 shares on 06/20/2021
- 2,739 shares on 06/20/2022
Recent trading activity shows Scher has already sold 8,200 shares for total proceeds of $198,604 through five separate transactions on 06/26/2025. The filing confirms no knowledge of material adverse information regarding Lifeway Foods' operations.